financetom
Business
financetom
/
Business
/
Gilead Sciences Collaborates With PANTHERx Rare for Livdelzi Distribution
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gilead Sciences Collaborates With PANTHERx Rare for Livdelzi Distribution
Aug 16, 2024 10:55 AM

01:39 PM EDT, 08/16/2024 (MT Newswires) -- Gilead Sciences ( GILD ) is collaborating with PANTHERx Rare to distribute Livdelzi, a treatment for primary biliary cholangitis in adults, PANTHERx Rare said Friday.

Financial details of the collaboration weren't disclosed.

Primary biliary cholangitis is a liver disease affecting the bile ducts.

Price: 73.81, Change: -0.53, Percent Change: -0.71

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved